Autoimmunity in dilated cardiomyopathy
暂无分享,去创建一个
M. Herzum | B. Maisch | Bernhard Maisch | A. Richter | Günter Hufnagel | Ute Schönian | Matthias Herzum | Michael Ritter | Anette Richter | M. Ritter | G. Hufnagel | U. Schönian
[1] M. Herzum,et al. Cytomegalovirus associated inflammatory heart muscle disease. , 1993, Scandinavian journal of infectious diseases. Supplementum.
[2] J. Mason,et al. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. , 1980, The American journal of cardiology.
[3] P. Lodge,et al. Coxsackievirus B-3 myocarditis in Balb/c mice. Evidence for autoimmunity to myocyte antigens. , 1984, The American journal of pathology.
[4] M. Herzum,et al. Four years of experience in endomyocardial biopsy —An immunohistologic approach , 2005, Heart and Vessels.
[5] I. Palacios,et al. Culture and characterization of lymphocytic infiltrates from endomyocardial biopsies of patients with idiopathic myocarditis , 1987 .
[6] Jeffrey L. Anderson,et al. Immunofluorescence Microscopy in the Diagnosis and Follow-up of Patients Suspected of Having Inflammatory Heart Disease , 1988 .
[7] B. Maisch,et al. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. , 1983, The American journal of cardiology.
[8] B. Maisch,et al. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. , 1982, Clinical and experimental immunology.
[9] Woodruff Jf. Viral myocarditis. A review. , 1980 .
[10] W. Abelmann,et al. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. , 1990, Circulation.
[11] G. Wallukat,et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. , 1994, Circulation.
[12] K. Beisel,et al. Postinfectious Autoimmunity: Two Distinct Phases of Coxsackievirus B3‐Induced Myocarditis a , 1986, Annals of the New York Academy of Sciences.
[13] F. Camerini,et al. Immunosuppressive therapy for myocarditis. , 1995, The New England journal of medicine.
[14] B Maisch,et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. , 1996, Circulation.
[15] F. Lottspeich,et al. Characterization of relevant membrane antigens by two-dimensional immunoblot and n-terminal sequence analysis in patients with myocarditis. , 1995, European heart journal.
[16] M. Herzum,et al. Immunosuppressive treatment for myocarditis and dilated cardiomyopathy. , 1995, European heart journal.
[17] G. Mudge,et al. Results of heart transplantation for active lymphocytic myocarditis. , 1990, The Journal of heart transplantation.
[18] P. Lodge,et al. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. , 1987, The American journal of pathology.
[19] E. Borda,et al. T lymphocytes from T. cruzi-infected mice alter heart contractility: participation of arachidonic acid metabolites. , 1992, Journal of molecular and cellular cardiology.
[20] J. Towbin,et al. Acute Myocarditis : Rapid Diagnosis by PCR in Children 331 TABLE 1 . Dallas Criteria * General definition : Myocardial cell injury with degeneration or necrosis with inflammatory infiltrate not due to ischemia , 2005 .
[21] B. Maisch. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury , 2004, Springer Seminars in Immunopathology.
[22] H. Jomaa,et al. Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis. , 1995, Journal of molecular and cellular cardiology.
[23] I. Goldenberg,et al. Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy. , 1989, Circulation research.
[24] K. Beisel,et al. Cardiac myosin induces myocarditis in genetically predisposed mice. , 1987, Journal of immunology.
[25] M. Morad,et al. Antibodies against ADP-ATP carrier enhance Ca2+ current in isolated cardiac myocytes. , 1988, The American journal of physiology.
[26] J. Carlquist,et al. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies. , 1991, Circulation.
[27] H. Schultheiss,et al. Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy. , 1985, Journal of molecular and cellular cardiology.
[28] B. Maisch,et al. Does CMV infection play a role in myocarditis? New aspects from in-situ hybridization. , 1991, European heart journal.
[29] C. Hengstenberg,et al. Are antisarcolemmal (ASAs) and antimyolemmal antibodies (AMLAs) "natural" antibodies? , 1991, Basic research in cardiology.
[30] K. Beisel,et al. Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice. , 1986, Journal of immunology.
[31] B. Maisch,et al. Demonstration of organ specific antibodies against heart mitochondria (anti-M7) in sera from patients with some forms of heart diseases. , 1984, Clinical and experimental immunology.
[32] S. Huber,et al. Cellular immune mechanisms in Coxsackievirus group B, type 3 induced myocarditis in Balb/C mice. , 1983, Advances in experimental medicine and biology.
[33] K. Beisel,et al. Coxsackievirus induced myocarditis in mice: cardiac myosin autoantibodies do not cross-react with the virus. , 1987, Clinical and experimental immunology.
[34] M. Herzum,et al. Circulating immune complexes in perimyocarditis and infective endocarditis , 1987 .
[35] S. Boyden,et al. Natural antibodies and the immune response. , 1966, Advances in immunology.
[36] H. Schultheiss,et al. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. , 1989, Circulation research.
[37] J E Parrillo,et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.
[38] M. Herzum,et al. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. , 1994, Journal of molecular and cellular cardiology.
[39] A. Matsumori,et al. Therapeutic Effect of Anti‐Tumor Necrosis Factor‐α Antibody on the Murine Model of Viral Myocarditis Induced by Encephalomyocarditis Virus , 1994, Circulation.
[40] C. Hengstenberg,et al. Immunosuppressive treatment in autoreactive myocarditis--results from a controlled trial. , 1994, Postgraduate medical journal.
[41] K. Beisel,et al. Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens. , 1987, Clinical immunology and immunopathology.
[42] W. Edwards,et al. Myocarditis. A histopathologic definition and classification. , 1987, The American journal of cardiovascular pathology.
[43] C. Hengstenberg,et al. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID). , 1995, European heart journal.
[44] B. Maisch,et al. Assessment of cytomegalovirus DNA and protein expression in patients with myocarditis. , 1993, Clinical immunology and immunopathology.
[45] N. Bowles,et al. DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.
[46] J. Mcanulty,et al. Lack of objective improvement in ventricular systolic function in patients with myocarditis treated with azathioprine and prednisone. , 1985, Journal of the American College of Cardiology.
[47] P. Hofschneider,et al. Viral heart disease , 2004, Springer Seminars in Immunopathology.
[48] B. Maisch,et al. Assessment of antibody mediated cytolysis of adult cardiocytes isolated by centrifugation in a continuous gradient of Percoll in patients with acute myocarditis. , 1981, Journal of immunological methods.
[49] J. Robinson,et al. The effects of cyclosporine on acute murine Coxsackie B3 myocarditis. , 1986, Circulation.
[50] B. Maisch,et al. Immune reactions in tuberculous and chronic constrictive pericarditis. Clinical data and diagnostic significance of antimyocardial antibodies. , 1982, The American journal of cardiology.
[51] B. Maisch,et al. Cytomegalovirus-associated heart muscle disease. , 1995, European heart journal.
[52] N. Fowler,et al. Immunologic findings in idiopathic cardiomyopathy: a prospective serial study. , 1973, American heart journal.
[53] B. McManus,et al. A molecular and serologic evaluation of enteroviral involvement in human myocarditis. , 1990, Journal of molecular and cellular cardiology.
[54] B. Maisch,et al. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. , 1993, Circulation.
[55] G. Schreiner,et al. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[56] B. Maisch. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. , 1986, Basic research in cardiology.
[57] Craven Pc. Interaction of ketoconazole with rifampin and isoniazid. , 1985 .
[58] B. McManus,et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. , 1995, The New England journal of medicine.
[59] B. Maisch,et al. The use of endomyocardial biopsy in heart failure. , 1988, European heart journal.
[60] P. Hofschneider,et al. Effect of Interferon on the Replication of Coxsackie B3 Virus in Cultured Human Fetal Heart Cells , 1984 .
[61] A. Heim,et al. Subclassification of dilated cardiomyopathy and interferon treatment. , 1995, European heart journal.